| Full Name | Esther Yu |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | Psc 475, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619693751 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 0810008299 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Esther Yu, Psc 474 Box 4904, Fpo, AP 96351-0050 Ph: () - | Esther Yu, Psc 475, Fpo, AP 96350-9998 Ph: (315) 243-5171 |
News Archive
Mettler-Toledo Safeline, the leading metal detection technology specialist, has developed a range of HDS Pipeline Detectors based on its well-proven Signature platform. This innovative pipeline metal detection solution was originally developed specifically for use on vacuum filling lines where it delivers unrivalled detection sensitivity and stability, as well as user-friendly operation in potentially harsh or extreme working environments.
RegeneRx Biopharmaceuticals, Inc. announced today that the first patient has been screened and is being enrolled in a Phase 2 clinical trial testing the Company's drug candidate RGN-259 in patients with dry eye associated with graft vs. host disease. The double-blind, placebo-controlled, investigator-sponsored trial is expected to enroll a total of 20 patients over the next several months, with data reported later in 2011. RGN-259 is a sterile, preservative-free topical eye drop formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4.
A healthy person's genome contains 46 chromosomes, but an individual cell can contain less. Contemporary methods allow to determine the value of losses rather accurately. The Tomsk researchers' effort has been supported by the Russian Foundation for Basic Research.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced that the company's proposed research collaboration with the University of Massachusetts Medical School has been selected for Cooperative Research Matching Grant funding by the Massachusetts Life Sciences Center.
BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has recently completed its $13.7M Series B round of funding, which included the conversion of a $1M State of Texas Emerging Technology Fund (ETF) award.
› Verified 3 days ago
Daniel Northington, PHD Psychologist Medicare: Medicare Enrolled Practice Location: Nmrtc Okinawa, Psc 482, Fpo, AP 96362 Phone: 805-235-3425 | |
Dr. Odelia Nicole Mcfadden, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Uss Carl Vinson, Unit 100111, Fpo, AP 96629 Phone: 267-709-3521 | |
Allison Conforte, M.ED., ED.S., PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: U.s. Nmrtc Yokosuka, Fpo, AP 96350 Phone: 315-243-8649 | |
Dr. Felecia D. Sheffield, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Naf Atsugi Bldg 21, Atsugi, Japan, Fpo, AP 96306 Phone: 315-264-3958 | |
Dr. Ivan Ryota Irie, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 315-243-5171 | |
Debra Hoffmann Houst, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Medical Department, Uss Carl Vinson Cvn 70, Fpo, AP 96629 Phone: 757-953-5814 | |
Eguono Voke Akpoduado, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: U.s Nmrtc Yokosuka, Naval Hospital, Fpo, AP 96350 Phone: 315-243-8649 |